View in EDS

IL-33 induces NF-κB activation in ILC2 that can be suppressed by in vivo and ex vivo 17β-estradiol.

Saved in:
Bibliographic Details
Title: IL-33 induces NF-κB activation in ILC2 that can be suppressed by in vivo and ex vivo 17β-estradiol.
Authors: Trivedi S; Division of Infectious Disease, Department of Internal Medicine, University of Utah, Salt Lake City, UT, United States.; George E Wahlen Department of Veterans Affairs Medical Center, VA Salt Lake City Health Care System, Salt Lake City, UT, United States., Labuz D; Division of Infectious Disease, Department of Internal Medicine, University of Utah, Salt Lake City, UT, United States., Deering-Rice CE; Department of Pharmacology and Toxicology, University of Utah College of Pharmacy, Salt Lake City, UT, United States., Kim CU; Division of Pulmonary Medicine, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, United States., Christensen H; Division of Pulmonary Medicine, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, United States., Aamodt S; Division of Pulmonary Medicine, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, United States., Huecksteadt T; George E Wahlen Department of Veterans Affairs Medical Center, VA Salt Lake City Health Care System, Salt Lake City, UT, United States., Sanders K; George E Wahlen Department of Veterans Affairs Medical Center, VA Salt Lake City Health Care System, Salt Lake City, UT, United States.; Division of Pulmonary Medicine, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, United States., Warren KJ; George E Wahlen Department of Veterans Affairs Medical Center, VA Salt Lake City Health Care System, Salt Lake City, UT, United States.; Division of Pulmonary Medicine, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, United States.
Source: Frontiers in allergy [Front Allergy] 2022 Nov 25; Vol. 3, pp. 1062412. Date of Electronic Publication: 2022 Nov 25 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9918227355906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2673-6101 (Electronic) Linking ISSN: 26736101 NLM ISO Abbreviation: Front Allergy Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2673-6101
DOI:10.3389/falgy.2022.1062412